FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385762384> ?p ?o ?g. }

• W4385762384 abstract "Bullous pemphigoid (BP) is the most common autoimmune blistering disease. Oral steroids are the standard treatment. We have updated this review, which was first published in 2002, because several new treatments have since been tried.To assess the effects of treatments for bullous pemphigoid.We updated searches of the following databases to November 2021: Cochrane Skin Specialised Register, CENTRAL, MEDLINE, and Embase. We searched five trial databases to January 2022, and checked the reference lists of included studies for further references to relevant randomised controlled trials (RCTs).RCTs of treatments for immunofluorescence-confirmed bullous pemphigoid.At least two review authors, working independently, evaluated the studies against the review's inclusion criteria and extracted data from included studies. Using GRADE methodology, we assessed the certainty of the evidence for each outcome in each comparison. Our primary outcomes were healing of skin lesions and mortality.We identified 14 RCTs (1442 participants). The main treatment modalities assessed were oral steroids, topical steroids, and the oral anti-inflammatory antibiotic doxycycline. Most studies reported mortality but adverse events and quality of life were not well reported. We decided to look at the primary outcomes 'disease control' and 'mortality'. Almost all studies investigated different comparisons; two studies were placebo-controlled. The results are therefore based on a single study for each comparison except azathioprine. Most studies involved only small numbers of participants. We assessed the risk of bias for all key outcomes as having 'some concerns' or high risk, due to missing data, inappropriate analysis, or insufficient information. Clobetasol propionate cream versus oral prednisone Compared to oral prednisone, clobetasol propionate cream applied over the whole body probably increases skin healing at day 21 (risk ratio (RR 1.08, 95% confidence interval (CI) 1.03 to 1.13; 1 study, 341 participants; moderate-certainty evidence). Skin healing at 21 days was seen in 99.8% of participants assigned to clobetasol and 92.4% of participants assigned to prednisone. Clobetasol propionate cream applied over the whole body compared to oral prednisone may reduce mortality at one year (RR 0.73, 95% CI 0.53 to 1.01; 1 study, 341 participants; low-certainty evidence). Death occurred in 26.5% (45/170) of participants assigned to clobetasol and 36.3% (62/171) of participants assigned to oral prednisone. This study did not measure quality of life. Clobetasol propionate cream may reduce risk of severe complications by day 21 compared with oral prednisone (RR 0.65, 95% CI 0.50 to 0.86; 1 study, 341 participants; low-certainty evidence). Mild clobetasol propionate cream regimen (10 to 30 g/day) versus standard clobetasol propionate cream regimen (40 g/day) A mild regimen of topical clobetasol propionate applied over the whole body compared to the standard regimen probably does not change skin healing at day 21 (RR 1.00, 95% CI 0.97 to 1.03; 1 study, 312 participants; moderate-certainty evidence). Both groups showed complete healing of lesions at day 21 in 98% participants. A mild regimen of topical clobetasol propionate applied over the whole body compared to the standard regimen may not change mortality at one year (RR 1.00, 95% CI 0.75 to 1.32; 1 study, 312 participants; low-certainty evidence), which occurred in 118/312 (37.9%) participants. This study did not measure quality of life. A mild regimen of topical clobetasol propionate applied over the whole body compared to the standard regimen may not change adverse events at one year (RR 0.94, 95% CI 0.78 to 1.14; 1 study, 309 participants; low-certainty evidence). Doxycycline versus prednisolone Compared to prednisolone (0.5 mg/kg/day), doxycycline (200 mg/day) induces less skin healing at six weeks (RR 0.81, 95% CI 0.72 to 0.92; 1 study, 213 participants; high-certainty evidence). Complete skin healing was reported in 73.8% of participants assigned to doxycycline and 91.1% assigned to prednisolone. Doxycycline compared to prednisolone probably decreases mortality at one year (RR 0.25, 95% CI 0.07 to 0.89; number needed to treat for an additional beneficial outcome (NNTB) = 14; 1 study, 234 participants; moderate-certainty evidence). Mortality occurred in 2.4% (3/132) of participants with doxycycline and 9.7% (11/121) with prednisolone. Compared to prednisolone, doxycycline improved quality of life at one year (mean difference 1.8 points lower, which is more favourable on the Dermatology Life Quality Index, 95% CI 1.02 to 2.58 lower; 1 study, 234 participants; high-certainty evidence). Doxycycline compared to prednisolone probably reduces severe or life-threatening treatment-related adverse events at one year (RR 0.59, 95% CI 0.35 to 0.99; 1 study, 234 participants; moderate-certainty evidence). Prednisone plus azathioprine versus prednisone It is unclear whether azathioprine plus prednisone compared to prednisone alone affects skin healing or mortality because there was only very low-certainty evidence from two trials (98 participants). These studies did not measure quality of life. Adverse events were reported in a total of 20/48 (42%) participants assigned to azathioprine plus prednisone and 15/44 (34%) participants assigned to prednisone. Nicotinamide plus tetracycline versus prednisone It is unclear whether nicotinamide plus tetracycline compared to prednisone affects skin healing or mortality because there was only very low-certainty evidence from one trial (18 participants). This study did not measure quality of life. Fewer adverse events were reported in the nicotinamide group. Methylprednisolone plus azathioprine versus methylprednisolone plus dapsone It is unclear whether azathioprine plus methylprednisolone compared to dapsone plus methylprednisolone affects skin healing or mortality because there was only very low-certainty evidence from one trial (54 participants). This study did not measure quality of life. A total of 18 adverse events were reported in the azathioprine group and 13 in the dapsone group.Clobetasol propionate cream applied over the whole body is probably similarly effective as, and may cause less mortality than, oral prednisone for treating bullous pemphigoid. Lower-dose clobetasol propionate cream applied over the whole body is probably similarly effective as standard-dose clobetasol propionate cream and has similar mortality. Doxycycline is less effective but causes less mortality than prednisolone for treating bullous pemphigoid. Other treatments need further investigation." @default.
• W4385762384 created "2023-08-12" @default.
• W4385762384 creator A5000758369 @default.
• W4385762384 creator A5009926815 @default.
• W4385762384 creator A5022274311 @default.
• W4385762384 creator A5049764403 @default.
• W4385762384 creator A5050390256 @default.
• W4385762384 creator A5078937709 @default.
• W4385762384 creator A5080537232 @default.
• W4385762384 date "2023-08-11" @default.
• W4385762384 modified "2023-09-26" @default.
• W4385762384 title "Interventions for bullous pemphigoid" @default.
• W4385762384 cites W1480729244 @default.
• W4385762384 cites W1485896673 @default.
• W4385762384 cites W1537972189 @default.
• W4385762384 cites W1812787420 @default.
• W4385762384 cites W1892976117 @default.
• W4385762384 cites W1939086364 @default.
• W4385762384 cites W1964267502 @default.
• W4385762384 cites W1965228868 @default.
• W4385762384 cites W1966220656 @default.
• W4385762384 cites W1969239138 @default.
• W4385762384 cites W1973651706 @default.
• W4385762384 cites W1976318914 @default.
• W4385762384 cites W1978948690 @default.
• W4385762384 cites W1981881616 @default.
• W4385762384 cites W1986215651 @default.
• W4385762384 cites W1987504124 @default.
• W4385762384 cites W1995478520 @default.
• W4385762384 cites W1995593160 @default.
• W4385762384 cites W1995656800 @default.
• W4385762384 cites W2003277956 @default.
• W4385762384 cites W2006779897 @default.
• W4385762384 cites W2007239126 @default.
• W4385762384 cites W2014493170 @default.
• W4385762384 cites W2018479414 @default.
• W4385762384 cites W2025315326 @default.
• W4385762384 cites W2029273508 @default.
• W4385762384 cites W2033534196 @default.
• W4385762384 cites W2038693293 @default.
• W4385762384 cites W2040088974 @default.
• W4385762384 cites W2041556380 @default.
• W4385762384 cites W2052165797 @default.
• W4385762384 cites W2054414140 @default.
• W4385762384 cites W2054438253 @default.
• W4385762384 cites W2061904336 @default.
• W4385762384 cites W2072785143 @default.
• W4385762384 cites W2073867916 @default.
• W4385762384 cites W2076982024 @default.
• W4385762384 cites W2085109894 @default.
• W4385762384 cites W2085612109 @default.
• W4385762384 cites W2094595739 @default.
• W4385762384 cites W2097250945 @default.
• W4385762384 cites W2098708745 @default.
• W4385762384 cites W2101058073 @default.
• W4385762384 cites W2101880291 @default.
• W4385762384 cites W2104410199 @default.
• W4385762384 cites W2111620283 @default.
• W4385762384 cites W2113979191 @default.
• W4385762384 cites W2120803991 @default.
• W4385762384 cites W2123531321 @default.
• W4385762384 cites W2127200831 @default.
• W4385762384 cites W2131558828 @default.
• W4385762384 cites W2131943685 @default.
• W4385762384 cites W2134091132 @default.
• W4385762384 cites W2135033359 @default.
• W4385762384 cites W2148270586 @default.
• W4385762384 cites W2152599151 @default.
• W4385762384 cites W2156588802 @default.
• W4385762384 cites W2158998701 @default.
• W4385762384 cites W2164385416 @default.
• W4385762384 cites W2166680972 @default.
• W4385762384 cites W2169877598 @default.
• W4385762384 cites W2187935508 @default.
• W4385762384 cites W2203432795 @default.
• W4385762384 cites W2388130102 @default.
• W4385762384 cites W2396544847 @default.
• W4385762384 cites W2398604610 @default.
• W4385762384 cites W2412172939 @default.
• W4385762384 cites W2418494959 @default.
• W4385762384 cites W2519102334 @default.
• W4385762384 cites W2529243499 @default.
• W4385762384 cites W2552494309 @default.
• W4385762384 cites W2555773301 @default.
• W4385762384 cites W2575603189 @default.
• W4385762384 cites W2588368793 @default.
• W4385762384 cites W2596645337 @default.
• W4385762384 cites W2602517913 @default.
• W4385762384 cites W2610363602 @default.
• W4385762384 cites W2612492130 @default.
• W4385762384 cites W2742322977 @default.
• W4385762384 cites W2756905600 @default.
• W4385762384 cites W2791163322 @default.
• W4385762384 cites W2802582736 @default.
• W4385762384 cites W2901189024 @default.
• W4385762384 cites W2950569641 @default.
• W4385762384 cites W2996200386 @default.
• W4385762384 cites W3010967672 @default.
• W4385762384 cites W3128763841 @default.
• W4385762384 cites W3207627503 @default.

• next